Article Text

This article has a correction. Please see:

Download PDFPDF
Continuous-infusion vancomycin therapy for preterm neonates with suspected or documented Gram-positive infections: a new dosage schedule
  1. O Plan1,
  2. G Cambonie1,
  3. E Barbotte2,
  4. P Meyer1,
  5. C Devine1,
  6. C Milesi1,
  7. O Pidoux1,
  8. M Badr1,
  9. J C Picaud1
  1. 1
    CHU de Montpellier, Service de Néonatologie (Pediatrie 2), Hôpital A. de Villeneuve, Montpellier, France
  2. 2
    CHU de Montpellier, Departement d’Information Médicale, Hôpital A. de Villeneuve, Montpellier, France
  1. Professor J C Picaud, Service de Néonatologie (Pediatrie 2), Hôpital Arnaud de Villeneuve, 371 avenue doyen Gaston Giraud, 34295 Montpellier Cedex 5, France; jc-picaud{at}


Background: Intermittent infusion of vancomycin is widely used to treat late-onset sepsis in neonates. On the other hand, the continuous infusion of vancomycin could improve bactericidal efficacy since its action is time dependent.

Objective: To evaluate a simplified dosage schedule for continuous-infusion vancomycin therapy.

Methods: Prospective study in premature neonates (<34 weeks) with suspected coagulase-negative staphylococci (CoNS) sepsis. Before antibiotics at time zero (T0), serum creatinine was measured and blood cultures were collected. Vancomycin dosage began with 25 mg/kg/day or 15 mg/kg/day (period 1) and 30 mg/kg/day or 20 mg/kg/day (period 2) depending on whether serum creatinine was below or above 90 μmol/l. Two days after beginning treatment (first timepoint: T1), serum vancomycin was measured and second blood cultures were collected.

Results: Between June 2002 and December 2005, 145 neonates were evaluated. At birth, the median (interquartile range) body weight was 920 (500–1160) g and gestational age was 28 (26–29) weeks. At T1, serum vancomycin was within the required range in 74.5% of neonates (108/145). Serum vancomycin levels were higher in period 2 than in period 1 (20 mg/l vs 13 mg/l, p<0.05). At T0, 55% (80/145) of blood cultures were positive for CoNS, but 71% (57/80) were negative at T1. Four days after beginning treatment, 92% of subjects had recovered without removing the central venous catheter.

Conclusion: Using this simplified dosage schedule, bactericidal efficacy was maintained and most subjects had serum vancomycin concentrations within the therapeutic range.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests: None.

Linked Articles

  • Fantoms
    Ben Stenson
  • Correction
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health